A Mobile App to Improve 24-Hour Movement Guideline Adherence in Preschoolers
Part of paid clinical trials in Kansas City, Kansas.
- Sponsor
- University of Kansas Medical Center
- Study ID
- NCT06667661
- Status
- Recruiting
Conditions
- 24-Hour Movement Guidelines
- Child Development
- Cognition
- Feasibility Studies
- Health Education
- Healthy
- Mobile Application
- Motor Skills
- Parent-Child Relations
- Physical Activity
- Screen Time
- Sedentary Behaviors
- Sleep
Eligibility Criteria
- Sex
- ALL
- Age
- 3 Years - 4 Years
- Healthy Volunteers
- Accepted
Interventions
- Shining Star mHealth App — BEHAVIORALThe Shining Star mHealth App Intervention is a 12-week mobile health program designed to improve adherence to the 24-Hour Movement Guidelines (physical activity, screen time, and sleep) among preschool-aged children (3-4 years old). The intervention delivers weekly behavior-related goals and educational lessons to parents through a mobile app, including concise messages (\<500 characters) and links to additional resources. The app also includes gamification features, behavior trackers, and a \"Kids Corner\" for child-friendly content. Parents receive reminders and can engage with other participants through an optional chat forum.
Study Details
The goal of this clinical trial is to evaluate whether a home-based mHealth intervention can improve adherence to the 24-Hour Movement Guidelines in preschool-aged children (3-4 years old) who currently meet 0 or 1 of the guidelines for physical activity, sedentary behavior, and sleep. The main questions it aims to answer are: * Can the intervention increase the proportion of children meeting all three 24-Hour Movement Guidelines (physical activity, screen-time, and sleep)? * Is the intervention feasible for parents to implement, as measured by a parent feedback survey? Researchers will compare an intervention group to a waitlist control group to assess whether the intervention leads to increased guideline adherence. Parents and Participants: * Children will wear an accelerometer to track physical activity and sleep patterns. * Parents will use a mobile app that delivers weekly lessons and behavior-related goals to encourage healthy movement behaviors in their children. * Parents will complete questionnaires on their child's movement behaviors and development at baseline, 6 weeks, and 12 weeks. * Additionally, children will undergo motor skills assessments, and parents will provide feedback on cognitive development and behavioral changes.
Key Dates
- Start date
- Jan 29, 2025
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: 12-Week InterventionParticipants in the intervention group will receive access to the "Shining Star" mobile health application for 12 weeks. The app provides weekly lessons and behavior-related goals focused on improving adherence to the 24-Hour Movement Guidelines (physical activity, screen time, and sleep). Parents will receive concise messages (less than 500 characters) through the app, along with links to additional resources, gamification elements, and behavior trackers. Participants and participants will also complete physical activity and sleep assessments using accelerometers and questionnaires at baseline, Week 6, and Week 12.
- No Intervention: Wait-list ControlParticipants in the wait-list control group will receive no intervention during the initial 12 weeks. They will complete the same assessments (physical activity, screen time, sleep, motor skills, and cognition) at baseline, Week 6, and Week 12. After the 12-week period, they will be granted access to the Shining Star mobile app and receive all lessons and resources provided to the intervention group.
Primary Outcome Measure
Physical Activity (ActiGraph GT3X+ accelerometer) [ Time Frame: Baseline, Week 6, and Week 12 ]
Central Contacts
- Dr. Chelsea L Kracht, PhD913-588-1655
- Jesse D Lyle, MHSA785-766-1944
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | Dr. Chelsea L Kracht, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Kansas City, KS
Related Studies
- MAD Study of IA-14069PHASE1 · Recruiting · ILAb Co., Ltd. · Lenexa, Kansas
- Hyperpolarized 129Xe MRI Lung Health CohortRecruiting · University of Kansas Medical Center · Chicago, Illinois
- Promoting Active Therapy: Path to WellnessPHASE2 · Recruiting · Kansas State University · Manhattan, Kansas
- A Study of LY4088044 in Healthy ParticipantsPHASE1 · Recruiting · Eli Lilly and Company · Los Alamitos, California